Abstract Title:

Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line.

Abstract Source:

Chin J Integr Med. 2014 Aug ;20(8):618-23. Epub 2013 Jun 15. PMID: 23771805

Abstract Author(s):

Shokoofe Noori, Zuhair M Hassan, Vida Farsam

Article Affiliation:

Shokoofe Noori


OBJECTIVE: To investigate the possible mechanism through which Artemisinin induced apoptosis in pancreatic cell line.

METHODS: Column chromatography, thin layer chromatography (TLC) and proton NMR spectroscopy were used to purify Artemisinin. The flowcytometry was employed to detect apoptosis and reactive oxygen species (ROS).

RESULTS: The results indicated that 50% inhibiting concentration (IC50 value) for pancreatic cell line (RIN) was 45μmol/L of Artemisinin. Artemisinin had no cytotoxic effect on the growth of peripheral blood lymphocytes. The mechanism of apoptosis was evaluated by measuring intracellular ROS. It was shown that Artemisinin-induced apoptosis occurred independently of the binding of CD95L to CD95 receptor in the RIN cells. Moreover, Artemisinin, in a dose-dependent manner, could significantly increase the level of ROS.

CONCLUSION: Artemisinin can induce apoptosis in the RIN cells via the generation of ROS and triggering the intrinsic pathway of cell death.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.